Based on the Wall Street analyst consensus for 43 of HRTS’s holdings.
HRTS 12 Month Forecast
Average Price Target
$46.01▲(17.23% Upside)
Based on Wall Street analyst 12-month price targets for 43 of Tema Cardiovascular and Metabolic ETF’s holdings in the last 3 months. The average price target is $46.01 with a high forecast of $55.15 and a low forecast of $35.95. The average price target represents a 17.23% change from the last price of $39.24.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$55.15
Average$46.01
Low$35.95
Past 12 Months12 Month Forecast$31$37.3$43.5$49.8$56Feb2026May2026Aug2026Nov2026Nov2027
What is HRTS’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 43 of HRTS’s holdings, Tema Cardiovascular and Metabolic ETF’s 12-month average price target is $46.01.
What is HRTS’s upside potential, based on the analysts’ average price target?
HRTS’s average price target of $46.01 represents a 17.23% upside from its last price of $39.24.
Is HRTS a Buy, Sell or Hold?
Tema Cardiovascular and Metabolic ETF has a consensus rating of Strong Buy, based on the analyst consensus for 43 of HRTS’s holdings: 40 rated Buy, 3 rated Hold and 0 rated Sell.
What is Tema Cardiovascular and Metabolic ETF’s price target?
The average price target for Tema Cardiovascular and Metabolic ETF is $46.01, based on Wall Street analyst 12-month price targets for 43 of HRTS’s holdings, issued in the past 3 months. The highest price target is $55.15 and the lowest is $35.95. The average price target represents a 17.23% increase from the last price of $39.24.
What is HRTS’s expense ratio?
HRTS’s expense ratio is 0.75%.
How many holdings does HRTS have?
HRTS holds 47 assets.
How can I buy shares of HRTS?
You can buy shares of HRTS through a brokerage account. Compare brokers on our Best Online Brokers page.